Braun Stacey Associates’s Corteva CTVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-54,736
Closed -$2.8M 117
2023
Q3
$2.8M Sell
54,736
-180,416
-77% -$9.55M 0.14% 96
2023
Q2
$13.5M Sell
235,152
-228,232
-49% -$13.3M 0.63% 75
2023
Q1
$27.9M Buy
463,384
+259,827
+128% +$15.9M 0.73% 65
2022
Q4
$12M Buy
+203,557
New +$12.9M 0.68% 70

Other funds holding CTVA

Braun Stacey Associates's CTVA Position: Q4 2023 in Review

Braun Stacey Associates sold out of Corteva (CTVA) in Q4 2023, closing a stake of 54,736 shares — an estimated $2.8M sold.

Braun Stacey Associates first reported a position in CTVA in Q4 2022 and held it in 4 quarters. The position peaked at $27.9M in Q1 2023. 1,231 funds tracked by Wall St. Rank hold CTVA as of Q4 2023.

  • Braun Stacey Associates reported no remaining Corteva position as of Q4 2023 after selling out during the quarter.
  • Braun Stacey Associates sold 54,736 Corteva shares in Q4 2023, an estimated $2.8M.
  • Braun Stacey Associates first reported a position in Corteva in Q4 2022 and held it in 4 quarters.
  • Braun Stacey Associates's Corteva position peaked at $27.9M in Q1 2023.
  • 1,231 funds tracked by Wall St. Rank held Corteva as of Q4 2023.

Based on Braun Stacey Associates's 13F filing for Q4 2023, filed 23 Jan 2024.